<DOC>
	<DOCNO>NCT02118714</DOCNO>
	<brief_summary>This study conduct evaluate effect Atrasentan sperm production function testicle male subject Type 1 2 Diabetes Nephropathy .</brief_summary>
	<brief_title>Atrasentan Spermatogenesis Testicular Function</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Atrasentan</mesh_term>
	<criteria>Males 30 75 year age Type 1 2 diabetes receive treatment least one antihyperglycemic medication angiotensinconverting enzyme inhibitor ( ACEi ) /angiotensin receptor blocker ( ARB ) ( reninangiotensin system [ RAS ] inhibitor ) Estimated Glomerular Filtration Rate ( eGFR ) equal great 35 mL/min Chronic Kidney Disease Epidemiology Collaboration ( CKDEPI ) Formula Urine AlbumintoCreatinine Ratio ( UACR ) equal great 30 less 5,000 mg/g creatinine . Able provide semen specimen require interval . Baseline sperm concentration equal great 30 million per mL . Treatment hormone suppressive agent cancer chemotherapy within past 6 month plan study . History severe peripheral edema facial edema unrelated trauma history myxedema prior 4 week prior screen . History pulmonary hypertension , pulmonary fibrosis lung disease require oxygen therapy . Documented diagnosis heart failure , previous hospitalization heart failure current constellation symptom ( dyspnea exertion , pedal edema , orthopnea , paroxysmal nocturnal dyspnea ) felt compatible heart failure , explain cause , change medication management direct heart failure . Currently receive receive hormone replacement therapy within 6 month prior screen .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Kidney Diseases</keyword>
	<keyword>Urologic Diseases</keyword>
	<keyword>Diabetes Complications</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Endocrine System Diseases</keyword>
	<keyword>Diabetic Nephropathies</keyword>
</DOC>